Attached files

file filename
EX-31.2 - EX-31.2 - BIOLASE, INCd331085dex312.htm
EX-32.2 - EX-32.2 - BIOLASE, INCd331085dex322.htm
EX-31.1 - EX-31.1 - BIOLASE, INCd331085dex311.htm
EX-32.1 - EX-32.1 - BIOLASE, INCd331085dex321.htm
EXCEL - IDEA: XBRL DOCUMENT - BIOLASE, INCFinancial_Report.xls

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q/A

 

 

(Mark One)

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

OR

 

  ¨ TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934

From the transition period from          to         .

Commission File Number 000-19627

 

 

BIOLASE, INC.

(Exact name of small business issuer as specified in its charter)

 

 

 

Delaware   87-0442441

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

4 Cromwell, Irvine, California 92618

(Address of principal executive offices)

(949) 361-1200

(Issuer’s telephone number)

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:.    Yes  x    No  ¨.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large Accelerated Filer    ¨       Accelerated Filer    x
Non-Accelerated Filer    ¨       Smaller Reporting Company    ¨

Indicate by a check mark whether the company is a shell company (as defined by Rule 12b-2 of the Exchange Act:    Yes  ¨    No  x.

The number of shares of the issuer’s common stock, $0.001 par value per share, outstanding as of August 3, 2012 was 31,084,982 shares.

 

 

 


AMENDMENT TO THE QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2012

EXPLANATORY NOTE

The purpose of this Amendment to our Quarterly Report on Form 10-Q for the period ended June 30, 2012 as filed with the Securities and Exchange Commission on August 9, 2012 is to furnish Exhibit 101 to the Form 10-Q as required by Rule 405 of Regulation S-T within the 30 day grace period provided by Rule 405(a)(2) of Regulation S-T.

No changes have been made to the Quarterly Report other than the furnishing of Exhibit 101 as described above. This Amendment to Form 10-Q does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify

or update in any way disclosures made in the Form 10-Q, as amended.

In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as a result of this Amendment to

Form 10-Q, the certifications pursuant to Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, filed and furnished, respectively as exhibits to the Original Quarterly Report on Form 10-Q have been re-executed and re-filed as of the date of this Amendment to Form 10-Q and are included as exhibits hereto.


ITEM 6. EXHIBITS

The following exhibits are included herein:

 

Exhibit
Number
   Name of Exhibit

31.1

   Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended

31.2

   Certification of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended

32.1

  

Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002

32.2

  

Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002

101

  

The following unaudited financial information from the Company’s Quarterly Report on Form 10-Q, for the period ended June 30, 2012, formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets,

(ii) Consolidated Statements of Comprehensive Loss, (iii) Consolidated Statements of Cash Flows, (iv) Notes to Consolidated Financial Statements

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: September 5, 2012

 

BIOLASE, INC.,

a Delaware Corporation

(registrant)

By:  

/s/ FEDERICO PIGNATELLI

  Federico Pignatelli
  Chief Executive Officer
  (Principal Executive Officer)
By:  

/s/ FREDERICK D. FURRY

  Frederick D. Furry
  Chief Financial Officer
  (Principal Financial and Accounting Officer)